HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haematological recovery in dyskeratosis congenita patients treated with danazol.

AuthorsAmin Islam, Shafquat Rafiq, Mike Kirwan, Amanda Walne, Jamie Cavenagh, Tom Vulliamy, Inderjeet Dokal
JournalBritish journal of haematology (Br J Haematol) Vol. 162 Issue 6 Pg. 854-6 (Sep 2013) ISSN: 1365-2141 [Electronic] England
PMID23782100 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Danazol
Topics
  • Adult
  • Danazol (therapeutic use)
  • Dyskeratosis Congenita (blood, drug therapy, genetics)
  • Female
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: